Lilly and several other drugmakers such as Gilead Sciences, Pfizer Inc and Merck & Co Inc are racing to develop treatments or vaccines for the fast-spreading respiratory illness caused by the novel coronavirus.
Read More
Glenmark said it would conduct clinical trials in India of just favipiravir as a potential treatment for COVID-19.
Read More
India is now among the top 10 countries in the world regarding the total number of COVID-19 cases.
Read More
The race to create a vaccine is on – the country that gets there first stands to gain in more ways than one By Jyotsna Sharma
Read More
Institutions across Britain had begun enrolling up to 10,260 adults and children to see how well the human immune system responds to the vaccine and how safe it is
Read More
The Bengaluru-based company has received approval from the Drug Controller General of India to conduct human studies of favipiravir in the country, a Strides executive said on a post-earnings conference call.
Read More
The company reported a revenue of Rs 4,432 crore, up 10 per cent from the year-ago period.
Read More
In an interview with BW Businessworld, Dr. Vipul Aggarwal, Deputy CEO, National Health Authority, talks about India’s first and the world’s largest healthcare scheme that covers about 40% of the country’s population and it’s role is fighting COVID 19.
Read More
